FdaApplication
NDA 021071
Identifiers
- fda_app_no: NDA021071
Properties
| Property | Value |
|---|---|
| applicant_name | WOODWARD PHARMA SERVICES LLC |
| application_type | NDA |
| approval_date | 1999-05-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| AVANDIA | ROSIGLITAZONE MALEATE | EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| AVANDIA | ROSIGLITAZONE MALEATE | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| AVANDIA | ROSIGLITAZONE MALEATE | EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products